Literature DB >> 33035468

The changing demographics of COVID-19.

Priya Venkatesan.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33035468      PMCID: PMC7538108          DOI: 10.1016/S2213-2600(20)30461-6

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
As societies around the world begin to reopen after many months of lockdown, a worrying shift is emerging in the demographic of COVID-19 cases towards individuals aged younger than 40 years. According to an analysis of 6 million cases between February and July, 2020, the number of infected people aged 15–24 years increased from 4·5% to 15%, possibly resulting from a combination of increased socialising in younger age groups and reversion to previous routines, including attending workplaces, schools, and universities, plus better surveillance. The age shift has become even more pronounced recently, as a report from the US Centers for Disease Control and Prevention (CDC) showed that cases of COVID-19 in individuals aged 18–22 years in the USA increased by 55% between Aug 2 and Sept 5, 2020. Another report from the CDC showed that the number of cases of COVID-19 in the USA between June and August, 2020, was highest in the age group 20–29 years, accounting for more than 20% of the total. This is in stark contrast with the early days of the pandemic in March 2020, when the incidence of COVID-19 was highest in elderly people aged at least 60 years. Similarly, in England most new infections identified between Aug 17 and 30, 2020, were in individuals aged 20–29 years. John Edmunds (London School of Hygiene & Tropical Medicine, London, UK) is not surprised by these data, commenting “A range of different serological surveys [done] over recent months all suggest that young adults were more likely to be infected than older individuals. Hence, it might be that the pattern that we are witnessing now is not actually very different from the first part of the epidemic.” The excess figures in younger individuals has implications in terms of community transmission and infection of more vulnerable population groups. Many young people live with older people such as parents and grandparents, increasing the possibility of passing on infection to those likely to have severe disease. However, the findings might also be of concern for the younger individuals themselves. UK hospital admission data from the ISARIC4C study show an increase in excess hospital admissions since Aug 1, 2020, among women aged 20–40 years old. Of female patients admitted to hospital, 49 (12·0%) were age 21–30 years, versus 33 (8·1%) age 41–50 years, and 35 (8·6%) age 61–69 years. Of males admitted to hospital, only 17 (3·7%) were in the 21–30 years age bracket. Generally, patients admitted to hospital with COVID-19 after Aug 1 were younger than the overall cohort of patients admitted since the start of the pandemic. However, fewer patients in the later cohort required ventilation and had lower mortality (12% vs 31%) than the overall cohort. These data have raised some concerns. Calum Semple (University of Liverpool, Liverpool, UK) commented “Women in these age groups are being exposed more than men of the same age, and we are seeing more [hospital admissions for] women aged 20–40 years than expected based on previous observations”. The driving force behind this excess is, however, more complicated. Many of the severe cases of COVID-19 in hospital in this age group are individuals in the hospitality and service industries, such as bar managers and wait staff in restaurants—and most hospitality staff are women. The nature of the work itself increases the risk of exposure to the virus; and the greater the dose of the virus, the worse the disease. Individuals in the service industry are therefore at a high risk of exposure; and on the basis of these findings, the wearing of facemasks for hospitality staff as well as customers in bars and restaurants became mandatory in England from Sept 24, 2020. The take-home message is that no population group is completely safe from COVID-19 at the present time, and there is no room for complacency. Influenza season is also round the corner and data already collected in England, Scotland, and Wales between February and June, 2020, showed that patients with dual infections with influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus had a significantly longer hospital stay than patients with SARS-CoV-2 infection only (mean 16·4 days [SD 23·2] vs 7·4 days [13·7], p<0·001). Clearly, vigilance with vaccinations, social distancing, mask-wearing, and hand-washing, and unambiguous guidance on restrictions are still vitally important.
  15 in total

1.  Was Alpha deadlier than wild-type COVID? Analysis in rural England.

Authors:  Julii Brainard; Carlota Maria Grossi Sampedro; Anna Sweeting; Ric Fordham
Journal:  Infection       Date:  2022-03-05       Impact factor: 7.455

Review 2.  SARS coronavirus 2: from genome to infectome.

Authors:  Meghana Rastogi; Neha Pandey; Astha Shukla; Sunit K Singh
Journal:  Respir Res       Date:  2020-12-01

3.  Dynamic and features of SARS-CoV-2 infection in Gabon.

Authors:  Amandine Mveang Nzoghe; Guy-Stephan Padzys; Anicet Christel Maloupazoa Siawaya; Marisca Kandet Yattara; Marielle Leboueny; Rotimi Myrabelle Avome Houechenou; Eliode Cyrien Bongho; Cedrick Mba-Mezeme; Ofilia Mvoundza Ndjindji; Jean Claude Biteghe-Bi-Essone; Alain Boulende; Paulin N Essone; Carene Anne Alene Ndong Sima; Ulysse Minkobame; Carinne Zang Eyi; Bénédicte Ndeboko; Alexandru Voloc; Jean-François Meye; Simon Ategbo; Joel Fleury Djoba Siawaya
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

4.  Urban diversity and epidemic resilience: The case of the COVID-19.

Authors:  Ravit Hananel; Ram Fishman; Nechumi Malovicki-Yaffe
Journal:  Cities       Date:  2021-12-10

5.  Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.

Authors:  Vincent J Munster; Meaghan Flagg; Manmeet Singh; Claude Kwe Yinda; Brandi N Williamson; Friederike Feldmann; Lizzette Pérez-Pérez; Jonathan Schulz; Beniah Brumbaugh; Myndi G Holbrook; Danielle R Adney; Atsushi Okumura; Patrick W Hanley; Brian J Smith; Jamie Lovaglio; Sarah L Anzick; Craig Martens; Neeltje van Doremalen; Greg Saturday; Emmie de Wit
Journal:  Sci Adv       Date:  2021-10-22       Impact factor: 14.136

6.  SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.

Authors:  Maud Bouwman; Frits van Osch; Francy Crijns; Thera Trienekens; Jannet Mehagnoul-Schipper; Joop P van den Bergh; Janneke de Vries
Journal:  BMJ Open       Date:  2021-10-18       Impact factor: 3.006

7.  Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.

Authors:  Mihkel Plaas; Kadri Seppa; Nayana Gaur; Priit Kasenõmm; Mario Plaas
Journal:  Virology       Date:  2021-06-18       Impact factor: 3.513

8.  Prospective arrhythmia surveillance after a COVID-19 diagnosis.

Authors:  Thomas A Dewland; Isaac R Whitman; Sithu Win; Jose M Sanchez; Jeffrey E Olgin; Mark J Pletcher; Lekshmi Santhosh; Uday Kumar; Sean Joyce; Vivian Yang; Janet Hwang; Kelsey Ogomori; Noah Peyser; Cathy Horner; David Wen; Xochitl Butcher; Gregory M Marcus
Journal:  Open Heart       Date:  2022-01

9.  Physiotherapy management for COVID-19 in the acute hospital setting and beyond: an update to clinical practice recommendations.

Authors:  Peter Thomas; Claire Baldwin; Lisa Beach; Bernie Bissett; Ianthe Boden; Sherene Magana Cruz; Rik Gosselink; Catherine L Granger; Carol Hodgson; Anne E Holland; Alice Ym Jones; Michelle E Kho; Lisa van der Lee; Rachael Moses; George Ntoumenopoulos; Selina M Parry; Shane Patman
Journal:  J Physiother       Date:  2021-12-23       Impact factor: 7.000

10.  Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.

Authors:  Vincent J Munster; Meaghan Flagg; Manmeet Singh; Brandi N Williamson; Friederike Feldmann; Lizzette Pérez-Pérez; Beniah Brumbaugh; Myndi G Holbrook; Danielle R Adney; Atsushi Okumura; Patrick W Hanley; Brian J Smith; Jamie Lovaglio; Sarah L Anzick; Craig Martens; Neeltje van Doremalen; Greg Saturday; Emmie de Wit
Journal:  bioRxiv       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.